Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Modulating atherosclerotic plaque formation by targeting plasminogen receptor PlgRKT

Macrophages are essential for atherosclerotic plaque progression. Recently a plasminogen receptor, Plg-RKT was shown to modulate monocyte and macrophage migration and lipid metabolism. However, its function on atherosclerotic development is not described yet. The aim of this study was to define the effect...

J. Kral-Pointner, L. Boccuni, M. Mussbacher et al. · 0 citations
Open access Oct 2026

FH genotype stratifies LDL-C–lowering response and improves diagnostic discrimination in severe hypercholesterolemia

Severe hypercholesterolemia encompasses a broad range of phenotypes and treatment responses. Whether lipid-lowering therapy (LLT) effectiveness differs in patients with versus without pathogenic heterozygous familial hypercholesterolemia (FH) variants is not well defined, and it is uncertain if response patterns...

J. Bernhard, L. Galli, I. Undt et al. · 0 citations
Open access Oct 2026

Association of LDL-C/ApoB ratio with pathogenic variants in familial hypercholesterolemia

Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism marked by elevated low-density lipoprotein cholesterol (LDL-C) and premature atherosclerotic cardiovascular disease (ASCVD). Conventional diagnostic tools such as the Dutch Lipid Clinic Network (DLCN) score do not assess qualita...

J. Bernhard, F. Wollmann, L. Galli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.